Works by Brooks, Sander

Results: 8

Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 6, p. 1334, doi. 10.1002/cpt.2592

By:

Muehlan, Clemens;
Brooks, Sander;
Vaillant, Cedric;
Meinel, Michael;
Jacobs, Gabriël E.;
Zuiker, Rob G.;
Dingemanse, Jasper

Publication type:

Article

Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans.

Published in:

Translational Psychiatry, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41398-020-00937-9

By:

Salvadore, Giacomo;
Bonaventure, Pascal;
Shekhar, Anantha;
Johnson, Philip L.;
Lord, Brian;
Shireman, Brock T.;
Lebold, Terry P.;
Nepomuceno, Diane;
Dugovic, Christine;
Brooks, Sander;
Zuiker, Rob;
Bleys, Cathy;
Tatikola, Kanaka;
Remmerie, Bart;
Jacobs, Gabriel E.;
Schruers, Koen;
Moyer, John;
Nash, Abigail;
Van Nueten, Luc G. M.;
Drevets, Wayne C.

Publication type:

Article

Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.

Published in:

PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148850

By:

de Bruijn, Henriëtte S.;
Brooks, Sander;
van der Ploeg-van den Heuvel, Angélique;
ten Hagen, Timo L. M.;
de Haas, Ellen R. M.;
Robinson, Dominic J.

Publication type:

Article

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

Published in:

British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4658, doi. 10.1111/bcp.14884

By:

Mellion, Michelle L.;
Ronco, Lucienne;
Berends, Cecile L.;
Pagan, Lisa;
Brooks, Sander;
van Esdonk, Michiel J.;
van Brummelen, Emilie M. J.;
Odueyungbo, Adefowope;
Thompson, Lorin A.;
Hage, Michelle;
Badrising, Umesh A.;
Raines, Shane;
Tracewell, William G.;
van Engelen, Baziel;
Cadavid, Diego;
Groeneveld, Geert J.

Publication type:

Article

Clinical pharmacology of the dual orexin receptor antagonist ACT-541468 in elderly subjects: Exploration of pharmacokinetics, pharmacodynamics and tolerability following single-dose morning and repeated-dose evening administration.

Published in:

2020

By:

Muehlan, Clemens;
Boehler, Margaux;
Brooks, Sander;
Zuiker, Rob;
van Gerven, Joop;
Dingemanse, Jasper

Publication type:

journal article

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.

Published in:

2019

By:

Brooks, Sander;
Jacobs, Gabriël E.;
de Boer, Peter;
Kent, Justine M.;
Van Nueten, Luc;
van Amerongen, Guido;
Zuiker, Rob;
Kezic, Iva;
Luthringer, Remy;
van der Ark, Peter;
van Gerven, Joop M. A.;
Drevets, Wayne;
van Gerven, Joop Ma

Publication type:

journal article

Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Published in:

2020

By:

Berger, Benjamin;
Brooks, Sander;
Zuiker, Rob;
Richard, Muriel;
Muehlan, Clemens;
Dingemanse, Jasper

Publication type:

journal article

Sources of variability in the quantification of tissue optical properties by multidiameter single-fiber reflectance and fluorescence spectroscopy.

Published in:

Journal of Biomedical Optics, 2015, v. 20, n. 5, p. 1, doi. 10.1117/1.JBO.20.5.057002

By:

Brooks, Sander;
Hoy, Christopher L.;
Amelink, Arjen;
Robinson, Dominic J.;
Nijsten, Tamar E.

Publication type:

Article